Get the Stockscreener App
20.20
16.09%
2.80
After Hours:
20.20
Indivior Plc stock is traded at $20.20, with a volume of 24.14M.
It is up +16.09% in the last 24 hours and up +37.04% over the past month.
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
See More
Previous Close:
$17.40
Open:
$20.865
24h Volume:
24.14M
Relative Volume:
11.84
Market Cap:
$2.17B
Revenue:
$1.12B
Net Income/Loss:
$5.00M
P/E Ratio:
2,020.00
EPS:
0.01
Net Cash Flow:
$-383.00M
1W Performance:
+20.17%
1M Performance:
+37.04%
6M Performance:
+69.75%
1Y Performance:
+46.91%
1-Day Range:
$19.31
$21.01
1-Week Range:
$16.69
$21.01
52-Week Range:
$7.33
$21.01
Indivior Plc Stock (INDV) Company Profile
Name
Indivior Plc
Sector
Phone
804-379-1090
Address
234 BATH ROAD, SLOUGH, BERKSHIRE
Compare INDV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
20.20 | 2.17B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-22-25 | Resumed | Jefferies | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jul-23-24 | Initiated | Piper Sandler | Overweight |
| Apr-03-24 | Initiated | Craig Hallum | Buy |
| Jul-13-23 | Initiated | Northland Capital | Outperform |
Indivior Plc Stock (INDV) Latest News
Indivior Q2 2025 Earnings Call Transcript - MarketBeat
Indivior’s Prospects Rise with Bullish Ratings and Strategic Moves - StocksToTrade
INDIVIOR PLC SEC 10-Q Report - TradingView
Jefferies’ Buy Rating Boosts Indivior’s Market Outlook - timothysykes.com
Earnings call transcript: Indivior’s Q2 2025 earnings beat expectations, stock surges By Investing.com - Investing.com South Africa
Indivior's Strategic Momentum and SUBLOCADE Growth: A Convincing Case for Revisiting INDV in a High-Stakes OUD Market - AInvest
Indivior PLC Revises Earnings Guidance for the Year 2025 - MarketScreener
Indivior Q2 2025 slides: SUBLOCADE growth drives raised guidance, shares surge By Investing.com - Investing.com South Africa
Indivior Q2 2025 slides: SUBLOCADE growth drives raised guidance, shares surge - Investing.com UK
Indivior PLC (INDV) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
Indivior reports Q2 non-GAAP EPS 51c, consensus 25c - TipRanks
Indivior Raises 2025 Guidance After Strong Q2 Results - TipRanks
Indivior Q2 revenue $302mln, SUBLOCADE up 9% YoY. - AInvest
Indivior Reports Second Quarter 2025 Financial Results and Raises FY 2025 Financial Guidance - PR Newswire
How volatile is Indivior PLC stock compared to the marketBest Dividend Ideas For Beginners - jammulinksnews.com
What is the risk reward ratio of investing in Indivior PLC stockSmart Portfolio Strategy With High Returns - jammulinksnews.com
Indivior stock hits 52-week high at 17.56 USD By Investing.com - Investing.com Canada
Indivior PLC (INDV) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
What makes Indivior PLC stock price move sharplySmart Allocation Stock Pick Insights Gaining Interest - metal.it
Is Indivior PLC a Top Dividend Stock to Watch in 2025Triple Return Setup With Risk Control Explained - metal.it
Indivior PLC Uptrend in Early Stages Indicators Say YesSmart Money Tracking Signal Generator Activated - metal.it
Why Indivior PLC stock attracts strong analyst attentionBreakout Entry Signal Confirmation Tool Used - metal.it
What are the latest earnings results for Indivior PLCFinancial News Data Feed With Proven Results - jammulinksnews.com
Indivior to Report Second Quarter 2025 Financial Results and Host Webcast on July 31st - 富途牛牛
Drawdown in Indivior PLC May Be Nearing EndPattern Alert With ROI Driven Strategy Shared - metal.it
How does Indivior PLC generate profit in a changing economyMarket Forecast Opportunities Backed By Experts - jammulinksnews.com
Indivior PLC's Strategic Shift to Nasdaq and Leadership Reinvention: A Path to Long-Term Value Creation - AInvest
Indivior PLC (INDV) Reinvents Leadership, Moves Listing to Nasdaq - Insider Monkey
Jefferies Initiates Coverage on Indivior With Buy Rating, $20 Price Target - MarketScreener
What are the technical indicators suggesting about Indivior PLCMaximize returns with strategic trading plans - jammulinksnews.com
What are analysts’ price targets for Indivior PLC in the next 12 monthsRapid wealth multiplication - jammulinksnews.com
Is Indivior PLC stock overvalued or undervaluedCapitalize on momentum stocks early - jammulinksnews.com
What catalysts could drive Indivior PLC stock higher in 2025Outperformance with explosive growth - jammulinksnews.com
Cannabis Use Disorder (CUD) Pipeline Market Research Report 2025 Featuring Aelis Farma, Anebulo Pharmaceuticals, and Indivior - GlobeNewswire Inc.
Is Indivior PLC a good long term investmentBreakout portfolio performance - PrintWeekIndia
US Pharma Biz Indivior Cancels London Listing - Law360
Indivior Announces Completion of Cancellation of Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained | INDV Stock News - GuruFocus
Indivior Finalizes Exit from London Stock Exchange: What Shareholders Need to Know About Nasdaq-Only Trading - Stock Titan
Indivior's Strategic Delisting from the London Stock Exchange: A Closer Look at the Financial and Operational Benefits - AInvest
Indivior Announces Completion of Cancellation of Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained - PR Newswire
Indivior Announces Completion of Cancellation of Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained – Company AnnouncementFT.com - Financial Times
Barclays Adjusts Voting Rights in Indivior PLC - TipRanks
Indivior PLC (INDV) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo Finance
BlackRock, Inc.'s Strategic Acquisition of Indivior PLC Shares - GuruFocus
What analysts say about Indivior PLC stockExplosive trading opportunities - Autocar Professional
Indivior PLC Stock Analysis and ForecastSuperior return velocity - Autocar Professional
Indivior PLC (INDV) Q1 Earnings and Revenues Beat Estimates - MSN
Indivior Real World Evidence Study Finds Medications For Opioid Use Disorder Reduced Odds Of Emergency Department Visits - TradingView
Study: Extended-Release Buprenorphine Cuts Emergency Visits by 57% in Opioid Treatment | INDV Stock News - Stock Titan
Barclays Increases Stake in Indivior PLC - TipRanks
What drives Indivior PLC stock priceExceptional stock performance - jammulinksnews.com
Indivior Plc Stock (INDV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):